Literature DB >> 24136063

The prevalence of inflammatory back pain in a UK primary care population.

Louise Hamilton1, Alex Macgregor, Victoria Warmington, Edward Pinch, Karl Gaffney.   

Abstract

OBJECTIVE: Inflammatory back pain (IBP) is the earliest and most common symptom of axial SpA. However, there is very little information about the prevalence of IBP in the UK. In this cross-sectional cohort study we examined the prevalence of IBP in a UK primary care population using three published IBP criteria.
METHODS: Potential participants aged 18-80 years were identified from the records of a large general practice in Norfolk, UK, with 17 177 patients. Read codes were used to identify those who had consulted their general practitioner on at least one occasion with back pain. A self-completed screening questionnaire was sent to a sample of 978 patients, enquiring about symptoms of IBP and extra-spinal manifestations of SpA. Questionnaire responses were used to determine whether patients met the Assessment of SpondyloArthritis international Society (ASAS), Calin and Berlin IBP criteria.
RESULTS: Five hundred and five completed questionnaires were returned (response rate 51.6%). The median age of respondents was 60 years [interquartile range (IQR) 48-67] and 44.8% were male. The minimum prevalence of IBP among patients with at least one previous consultation for back pain was 7.7% (95% CI 6.2, 9.5) using the ASAS criteria, 13.5% (11.5, 15.8) using the Calin criteria and 15.4% (13.3, 17.8) using the Berlin criteria. There was no significant difference in prevalence between men and women, and between different age groups. Extrapolated to the practice population as a whole, the minimum prevalence of IBP in a UK primary care population is 1.7-3.4%.
CONCLUSION: The prevalence of IBP varies significantly depending on the criteria used for classification.

Entities:  

Keywords:  ankylosing spondylitis; classification; cohort; inflammatory back pain; prevalence; spondyloarthropathy

Mesh:

Year:  2013        PMID: 24136063     DOI: 10.1093/rheumatology/ket344

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  9 in total

Review 1.  Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis.

Authors:  Eric Gracey; Lars Vereecke; Dermot McGovern; Mareike Fröhling; Georg Schett; Silvio Danese; Martine De Vos; Filip Van den Bosch; Dirk Elewaut
Journal:  Nat Rev Rheumatol       Date:  2020-07-13       Impact factor: 20.543

2.  Clinical Evolution in Patients With New-Onset Inflammatory Back Pain: A Population-Based Cohort Study.

Authors:  Runsheng Wang; Cynthia S Crowson; Kerry Wright; Michael M Ward
Journal:  Arthritis Rheumatol       Date:  2018-05-13       Impact factor: 10.995

3.  An epidemiological study of the prevalence rate of inflammatory back pain and axial spondyloarthritis in a university in the south of China.

Authors:  Feng Tong; Qing Lv; Aimin Li; Linkai Fang; Zhongxing Luo; Junmei Feng; Jieruo Gu; Zhiming Lin
Journal:  Clin Rheumatol       Date:  2018-07-04       Impact factor: 2.980

4.  [Long version on the S3 guidelines for axial spondyloarthritis including Bechterew's disease and early forms, Update 2019 : Evidence-based guidelines of the German Society for Rheumatology (DGRh) and participating medical scientific specialist societies and other organizations].

Authors:  U Kiltz; J Braun; A Becker; J-F Chenot; M Dreimann; L Hammel; A Heiligenhaus; K-G Hermann; R Klett; D Krause; K-F Kreitner; U Lange; A Lauterbach; W Mau; R Mössner; U Oberschelp; S Philipp; U Pleyer; M Rudwaleit; E Schneider; T L Schulte; J Sieper; A Stallmach; B Swoboda; M Winking
Journal:  Z Rheumatol       Date:  2019-12       Impact factor: 1.372

5.  Ca2+-binding protein NECAB2 facilitates inflammatory pain hypersensitivity.

Authors:  Ming-Dong Zhang; Jie Su; Csaba Adori; Valentina Cinquina; Katarzyna Malenczyk; Fatima Girach; Changgeng Peng; Patrik Ernfors; Peter Löw; Lotta Borgius; Ole Kiehn; Masahiko Watanabe; Mathias Uhlén; Nicholas Mitsios; Jan Mulder; Tibor Harkany; Tomas Hökfelt
Journal:  J Clin Invest       Date:  2018-07-30       Impact factor: 14.808

6.  Increase in Dickkopf-1 Serum Level in Recent Spondyloarthritis. Data from the DESIR Cohort.

Authors:  Gaetane Nocturne; Stephan Pavy; Saida Boudaoud; Raphaèle Seror; Philippe Goupille; Philippe Chanson; Désirée van der Heijde; Floris van Gaalen; Francis Berenbaum; Xavier Mariette; Karine Briot; Antoine Feydy; Pascal Claudepierre; Philippe Dieudé; Joanne Nithitham; Kimberly E Taylor; Lindsey A Criswell; Maxime Dougados; Christian Roux; Corinne Miceli-Richard
Journal:  PLoS One       Date:  2015-08-27       Impact factor: 3.240

7.  The prevalence of axial spondyloarthritis in the UK: a cross-sectional cohort study.

Authors:  Louise Hamilton; Alex Macgregor; Andoni Toms; Victoria Warmington; Edward Pinch; Karl Gaffney
Journal:  BMC Musculoskelet Disord       Date:  2015-12-21       Impact factor: 2.362

8.  Diagnostic accuracy of inflammatory back pain for axial spondyloarthritis in rheumatological care.

Authors:  Denis Poddubnyy; Johanna Callhoff; Inge Spiller; Joachim Listing; Juergen Braun; Joachim Sieper; Martin Rudwaleit
Journal:  RMD Open       Date:  2018-12-05

9.  Gray matter alteration associated with pain catastrophizing in patients 6 months after lumbar disk surgery: a voxel-based morphometry study.

Authors:  Omar Chehadi; Boris Suchan; Kerstin Konietzny; Odo Köster; Tobias Schmidt-Wilcke; Monika I Hasenbring
Journal:  Pain Rep       Date:  2017-08-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.